BIO Bio-Rad Laboratories Inc

$303.73

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Updated On 8/22/2025

About Bio-Rad Laboratories Inc

Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets.

Website: https://www.bio-rad.com

Sector
LIFE SCIENCES
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
12208
Address
1000 ALFRED NOBEL DRIVE, HERCULES, CA, US
Valuation
Market Cap
$6.69B
P/E Ratio
nan
PEG Ratio
1.19
Price to Book
1.02
Performance
EPS
$-65.36
Dividend Yield
Profit Margin
-71.90%
ROE
-24.10%
Technicals
50D MA
$262.49
200D MA
$314.69
52W High
$387.99
52W Low
$215.38
Fundamentals
Shares Outstanding
23M
Target Price
$353.17
Beta
1.12

BIO EPS Estimates vs Actual

Estimated
Actual

BIO News & Sentiment

Aug 08, 2025 • Benzinga BULLISH
Baculovirus Expression System Market Poised for Significant Growth, Estimate to Hit USD 781.8 Million by 2032 | Coherent Market Insights
Burlingame, CA, Aug. 08, 2025 ( GLOBE NEWSWIRE ) -- The global Baculovirus Expression System Market is estimated to be valued at USD 436.0 Mn in 2025 and is expected to reach USD 781.8 Mn in 2032, exhibiting a compound annual growth rate ( CAGR ) of 8.7% from 2025 to 2032.
Aug 02, 2025 • Motley Fool NEUTRAL
Bio-Rad ( BIO ) Q2 EPS Jumps 51%
Bio-Rad Laboratories ( NYSE:BIO ) , a global leader in life science research and clinical diagnostics, posted its second quarter 2025 financial results on July 31, 2025. The most important news was a clear earnings and revenue beat: Adjusted earnings per share ( non-GAAP ) were $2.61 in Q2 2025, ...
Aug 01, 2025 • Benzinga SOMEWHAT-BULLISH
Bio-Rad Laboratories Analysts Raise Their Forecasts After Better-Than-Expected Q2 Earnings - Bio-Rad Laboratories ( NYSE:BIO )
Bio-Rad Laboratories, Inc. BIO reported better-than-expected second-quarter financial results on Thursday. Bio-Rad Laboratories reported quarterly earnings of $2.61 per share which beat the analyst consensus estimate of $1.76 per share.
Aug 01, 2025 • Benzinga BULLISH
Monolithic Power Systems, Workiva, Interface, AppFolio And Other Big Stocks Moving Higher On Friday - Rich Sparkle Holdings ( NASDAQ:ANPA ) , AppFolio ( NASDAQ:APPF )
U.S. stocks were lower, with the Dow Jones index falling around 500 points on Friday. Shares of Monolithic Power Systems, Inc. MPWR rose sharply during Friday's session after the company reported better-than-expected second-quarter financial results and issued third-quarter sales guidance above ...
Jul 24, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Earnings Preview: Bio-Rad Laboratories ( BIO ) Q2 Earnings Expected to Decline
Bio-Rad (BIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Jul 14, 2025 • Benzinga SOMEWHAT-BULLISH
In Situ Hybridization Market is expected to generate a revenue of USD 3.38 Billion by 2031, Globally, at 8.97% CAGR: Verified Market Research®
Lewes, Delaware, July 14, 2025 ( GLOBE NEWSWIRE ) -- The Global In Situ Hybridization Market Size is projected to grow at a CAGR of 8.97% from 2024 to 2031, according to a new report published by Verified Market Research®.
Sentiment Snapshot

Average Sentiment Score:

0.170
50 articles with scored sentiment

Overall Sentiment:

Bullish

BIO Reported Earnings

May 05, 2025
Mar 31, 2025 (Post market)
0.76 Surprise
  • Reported EPS: $2.54
  • Estimate: $1.78
  • Whisper:
  • Surprise %: 42.5%
Feb 13, 2025
Dec 31, 2024 (Pre market)
0.02 Surprise
  • Reported EPS: $2.90
  • Estimate: $2.88
  • Whisper:
  • Surprise %: 0.6%
Oct 30, 2024
Sep 30, 2024 (Post market)
0.85 Surprise
  • Reported EPS: $2.01
  • Estimate: $1.16
  • Whisper:
  • Surprise %: 73.3%
Aug 01, 2024
Jun 30, 2024 (Post market)
1.1 Surprise
  • Reported EPS: $3.11
  • Estimate: $2.01
  • Whisper:
  • Surprise %: 54.7%
May 07, 2024
Mar 31, 2024 (Post market)
0.14 Surprise
  • Reported EPS: $2.29
  • Estimate: $2.15
  • Whisper:
  • Surprise %: 6.5%
Feb 15, 2024
Dec 31, 2023 (Post market)
0.28 Surprise
  • Reported EPS: $3.10
  • Estimate: $2.82
  • Whisper:
  • Surprise %: 9.9%
Oct 26, 2023
Sep 30, 2023 (Post market)
-0.45 Surprise
  • Reported EPS: $2.33
  • Estimate: $2.78
  • Whisper:
  • Surprise %: -16.2%
Aug 03, 2023
Jun 30, 2023 (Post market)
0.32 Surprise
  • Reported EPS: $3.00
  • Estimate: $2.68
  • Whisper:
  • Surprise %: 11.9%
May 04, 2023
Mar 31, 2023 (Post market)
-0.2 Surprise
  • Reported EPS: $3.34
  • Estimate: $3.54
  • Whisper:
  • Surprise %: -5.7%

Financials